ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 61 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,502 | -15.6% | 331,668 | -10.5% | 0.30% | -8.1% |
| Q2 2023 | $589,386 | +175.2% | 370,683 | +24.2% | 0.32% | +208.7% |
| Q1 2023 | $214,187 | +23.8% | 298,560 | 0.0% | 0.10% | +2.0% |
| Q4 2022 | $173,016 | -39.1% | 298,560 | 0.0% | 0.10% | -41.4% |
| Q3 2022 | $284,000 | -33.2% | 298,560 | +20.0% | 0.17% | -30.4% |
| Q2 2022 | $425,000 | – | 248,800 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |